The Atherosclerosis Drugs Global Market Report 2023, provides comprehensive information on the atherosclerosis drugs market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.
Learn More On The Atherosclerosis Drugs Market’s Growth:
https://www.thebusinessresearchcompany.com/report/atherosclerosis-drugs-global-market-report
As per The Business Research Company’s Atherosclerosis Drugs Global Market Report 2023, the global atherosclerosis drugs market is expected to grow from $46.8 billion in 2022 to $48.72 billion in 2023 at a compound annual growth rate (CAGR) of 3.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and resulted in increased interest rates affecting many markets across the globe. The atherosclerosis drugs market is expected to reach $54.89 billion in 2027 at a CAGR of 3%.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=12621&type=smp
Product innovation is a key trend gaining popularity in the atherosclerosis drugs market going forward. Major companies operating in the atherosclerosis drugs market are developing innovative drugs and getting approvals to sustain their position in the market. For instance, in December 2021, Novartis AG, a Switzerland-based pharmaceutical company, received the US Food and Drug Administration (FDA) approval for Leqvio (inclisiran), a first-of-its-kind siRNA to lower cholesterol and treat people with atherosclerotic cardiovascular disease. This new drug is in the form of subcutaneous injection and reduces the amount of LDL (low-density lipoproteins) cholesterol in the bloodstream for the treatment of adults with clinical atherosclerotic cardiovascular disease. It provides a new option for patients who are not able to achieve their LDL cholesterol goals with other therapies.
The atherosclerosis drugs market is segmented:
1) By Drug Class: Anti-Platelet Medications, Fibric Acid And Omega-3 Fatty Acid Derivatives, Angiotensin-Covering Enzyme (ACE) Inhibitors, Diuretics, Cholesterol Lowering Medication, Beta Blockers, Calcium Channel Blockers, Other Drug Classe
2) By Route Of Administration: Oral, Injectable
3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies, Other Distribution Channels
North America was the largest region in the atherosclerosis drugs market in 2022.
The table of contents in TBRC’s atherosclerosis drugs market report includes:
1. Executive Summary
2. Atherosclerosis Drugs Market Characteristics
3. Atherosclerosis Drugs Market Trends And Strategies
4. Atherosclerosis Drugs Market – Macro Economic Scenario
5. Global Atherosclerosis Drugs Market Size and Growth
.
.
.
26. South America Atherosclerosis Drugs Market
27. Brazil Atherosclerosis Drugs Market
28. Middle East Atherosclerosis Drugs Market
29. Africa Atherosclerosis Drugs Market
30. Atherosclerosis Drugs Market Competitive Landscape And Company Profiles
Top Major Players:
- Johnson And Johnson Private Limited
- Pfizer Inc
- F. Hoffmann-La Roche AG
- AbbVie Inc
- Bayer AG
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
